Navigation Links
Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms
Date:5/10/2010

ountries as well as seven developed countries.

As a result nimotuzumab has been approved as a treatment for head and neck cancers and glioma, in 23 countries worldwide including Argentina, Brazil, China, India, Indonesia, Mexico and Ukraine. The consortium members license the drug from CIMAB and market it in their home countries. By including a south-south collaboration strategy, biotech firms can bypass pharma companies, retain greater presence in latter stages of the product's development, and potentially have a greater share of the revenues.

Vaccines for Africa's meningitis outbreak

To counter a meningitis outbreak in 2007 the World Health Organization (WHO) identified Bio-Manguinhos (Rio de Janeiro, Brazil), in collaboration with the Finlay Institute (Havana, Cuba), as the most suitable suppliers of a meningitis vaccine. They relied on their respective strengths in the development and manufacturing process and neither firm alone would have been able to respond so quickly and efficiently to this request. This shows how south-south collaboration can be harnessed to address a health threat spurred by demand and funding from an international organization.

South- South approach to dealing with HIV/AIDs based on local biodiversity

China and Thailand are working together to develop a remedy against HIV/AIDs based on Chinese biodiversity and knowledge from traditional Chinese medicine. After extensive animal testing in China, clinical trials began in Thailand where the incidence of HIV/AIDS is far higher. The herbal-based anti HIV drug -- Complex SH -- is the first to ever undergone Phase I, II, and III clinical trials. Complex SH is said to inhibit growth of HIV and kill the virus and has an efficacy rate of 89% when used alone, and even higher with other therapies. And all without the side effects that accompany a similar class of biomedical drugs.

The product is patented and has received regulator
'/>"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
McLaughlin-Rotman Centre for Global Health
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Hybrid computer materials may lead to faster, cheaper technology
2. Cheaper materials could be key to low-cost solar cells
3. Stanford researchers find a quicker, cheaper way to sort isotopes
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Amazing Treatment Relieves Serious Back Pain Without Dangerous Drugs, Injections or Surgery!
6. New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
7. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
8. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
9. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
10. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
11. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... solutions for drug discovery and related life ... consortium has chosen Genedata Selector as its ... (NGS) data. FUNGITECT is a European consortium ... fungal diseases via individualized anti-fungal drug therapies. ...
(Date:9/30/2014)... , Sept. 30, 2014  KemPharm, Inc., ... discovery and development of proprietary new molecular entity ... Patent and Trademark Office (USPTO) issued U.S. Patent ... entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl ... Making and Use Thereof." The patent, ...
(Date:9/30/2014)... MAR, Calif. , Sept. 30, 2014 ... for women,s health announces its receipt of a patent ... FemmyCycle menstrual cup has also received FDA clearance in ... Canada, and the CE in Europe. This patent is related ... conjunction with this issuance, the company is releasing FemmyCycle ...
(Date:9/30/2014)... The overall research objective was to ... and use. Most researchers outsource NGS technologies; however, ... within the next 12 months. Data accuracy and ... sequencing instruments. Disease-related research is the dominant use ... to surge, with half of the respondents planning ...
Breaking Biology Technology:FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2Global Next-generation Sequencing Trends 2
... GeneGo, Inc., the leading,systems biology tools company, announced ... Center of Excellence. MD Anderson researchers will have,institution-wide ... advanced support. MD Anderson specializes in cancer treatment ... clinical trials programs.,MetaCore will be used throughout many ...
... and VANCOUVER, Sept. 2 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals, ... the "Company") has,announced today that it has ... rights to develop and commercialize TOCOSOL(R),Paclitaxel. Under ... entitled to,receive royalty payments from future TOCOSOL ...
... EDISON, N.J., Sept. 1 PSKW, LLC, a ... the pharmaceutical,industry, announced today that it has significantly ... last year in the Supreme Court of the ... McKesson Specialty Arizona Inc.,("McKesson"), a wholly-owned subsidiary of ...
Cached Biology Technology:MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research 2OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals 2OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals 3PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application 2
(Date:9/30/2014)... a suite of perilous threats in today,s ocean. ... climate change, fragile coral ecosystems are disappearing at ... some species of corals surrounding the island of ... in their tropical environment: coral guard-crabs. New research ... Marine Station scientist Seabird McKeon and the museum,s ...
(Date:9/29/2014)... species of gut bacteria called Clostridium ramosum , coupled ... The work is published this week in mBio , ... , A research team from the German Institute of ... gut bacteria including C. ramosum gained weight when ... C. ramosum were less obese even when consuming a ...
(Date:9/29/2014)... 1970 and 2010 populations of mammals, birds, reptiles, ... percent, says the 2014 Living Planet Report released ... loss occurs disproportionately in low-income countriesand correlates with ... In addition to the precipitous decline in wildlife ... signs about the overall health of the planet. ...
Breaking Biology News(10 mins):Smithsonian scientists discover coral's best defender against an army of sea stars 2Gut bacteria promote obesity in mice 2Half of global wildlife lost, says new WWF report 2
... chemotherapy for the treatment of skin cancer is one ... researchers successfully synthesized a natural substance that shows exceptional ... U of A chemistry professor Dennis Hall said after ... produced the substance called Palmerolide A. "The potency ...
... DigitalPersona, Inc., a leader in fingerprint identity ... a leading supplier of point-of-sale (POS) software for ... NextGen POS and Classic POS solutions. WAND,s quick-service ... cashier accountability and deter unauthorized manager overrides. ...
... the blink of a geologic eye global temperatures were ... come by. Today, the largest island in the world is covered ... hot spot for climate scientists. Why? Because tiny bubbles ... about global warming: how fast and how much will ice ...
Cached Biology News:WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3As Greenland melts 2
...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
... Serum; U.S. sourced, ideal for ... quality; Low hemoglobin; Endotoxin: < ... of US origin; U.S. sourced, ... an uncompromising quality. Low hemoglobin ...
NEWBORN CALF SERUM AND PLASMA...
Biology Products: